Está en la página 1de 2

BDA Advises Zoetis on the Sale of Its Plant Health Business in Japan to Nippon

Soda

New York, NY, December 07, 2017 --(PR.com)-- BDA Partners (BDA) acted as the exclusive
financial advisor to Zoetis Inc, a leading animal health company, in connection with its agreement to
divest its Plant Health business in Japan to Nippon Soda Co, Ltd.

BDA Deal Team


Jeff Acton, Managing Director, Tokyo
Toshiaki Yokohara, Director, Tokyo
Alissa Schneideman, Analyst, Tokyo

About BDA
BDA Partners is a leader in cross-border investment banking involving Asia. BDA advises on M&A and
capital raising. BDA has been consistently owned and managed by the same team since 1996. BDA has a
track record of providing independent advice to blue-chip corporate and financial sponsor clients from
North America, Europe, and Asia. BDA is headquartered in New York with offices in London, Dubai,
Mumbai, Ho Chi Minh City, Singapore, Hong Kong, Shanghai, Seoul, and Tokyo. BDA formed
partnerships with William Blair & Company in 2011 and Development Bank of Japan in 2017.
www.bdapartners.com

US securities transactions are performed by BDA Partners' affiliate, BDA Advisors Inc, a broker-dealer
registered with the Securities and Exchange Commission (SEC). BDA Advisors Inc. is a member of the
Financial Industry Regulatory Authority (FINRA) and SIPC. In the UK, BDA Partners is authorised and
regulated by the Financial Conduct Authority (FCA). In Hong Kong, BDA Partners (HK) Ltd is licensed
and regulated by the Securities & Futures Commission (SFC) to conduct Type 1 and Type 4 regulated
activities to professional investors.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
BDA Partners
Euan Rellie
212-265-5300
Contact via Email
www.bdapartners.com

Online Version of Press Release:


You can read the online version of this press release at: https://www.pr.com/press-release/738251

Page 2/2
PR.com Press Release Distribution Terms of Use